Physician profile

Monique Jones

Manhasset, NY

NPI 1730253956

$9,228.10

in general payments reported to CMS, 2019-2025

7 companies · $247 in 2025

The $247 reported for 2025 was more than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$282.35

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alydia Health $4,800.00 2021
Coopersurgical, INC. $4,024.67 2021-2025 Sos
Organon LLC $152.62 2022-2023 Nexplanon
Regeneron Pharmaceuticals, INC. $120.88 2025
Pfizer INC. $91.01 2025
Roche Diagnostics Corporation $19.98 2019
Agile Therapeutics, INC. $18.94 2023 Twirla

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Monique Jones

$9,228.10

in general payments reported 2019-2025

Years
2019-2025
Top company
Alydia Health
Context
The $247 reported for 2025 was more than what a typical provider received nationally.

https://glasscript.com/doctor/1298018/monique-jones

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.